Sort
21,453 grants matching “tuberculosis”
Novel Antibacterial Agents That Target DNA Replication in Mycobacterium tuberculo
$300,000Michael J Pucci · Achillion Pharmaceuticals, Inc. · R43 · FY2010 · AI
A CD8+ T cell Diagnostic to Identify Children with Pulmonary Tuberculosis
$300,000Melissa R Nyendak · Viti, Inc. · R43 · FY2011 · AI
SQ641, new drug candidate to treat NTM infections
$300,000Venkata M Reddy · Sequella, Inc. · R43 · FY2010 · AI
SQ109 for treatment of MDR-TB
$300,000Leo Einck · Sequella, Inc. · R43 · FY2010 · AI
Advancing clemizole for hepatitis C: towards a pre-IND package
$300,000Jeffrey S Glenn · Eiger Group International, Inc. · R41 · FY2010 · AI
M.tuberculosis Genes Regulating Persistent Infection
$300,000Medical College Of Wisconsin · R01 · FY2005 · AI
Treatment of NTM Respiratory Infections with Inhaled Drug Delivery
$300,000Brian N Hansen · Aerophase, Inc. · R43 · FY2017 · AI
Dartmouth/Boston University AITRP
$300,000Dartmouth College · D43 · FY2005 · TW
Control of Immune responses by lipoxins during tuberculosis
$300,000Julio Aliberti · Cincinnati Childrens Hosp Med Ctr · R01 · FY2009 · AI
M.tuberculosis Genes Regulating Persistent Infection
$300,000Medical College Of Wisconsin · R01 · FY2003 · AI
Innovative approaches for tuberculosis control in Brazil
$300,000Federal University Of Rio De Janeiro · U2R · FY2005 · TW
Innovative Approaches for TB Control in Brazil
$300,000Johns Hopkins University · U2R · FY2005 · TW
3-Ketoacyl ACP Synthase III: A Novel Antibiotic Target
$300,000Virginia Commonwealth University · R01 · FY2003 · AI
Inhalable dry powders of mycobacteriophages for tuberculosis therapy
$300,000Zachary N Warnken · Via Therapeutics, Llc · R41 · FY2024 · AI
Targeting fungal ceramide synthases as new antifungals
$300,000Maurizio Del Poeta · Microrid Technologies, Inc. · R41 · FY2024 · AI
Dartmouth/Boston University AITRP
$300,000Dartmouth College · D43 · FY2004 · TW
GENETIC DISSECTION OF MYCOBACTERIAL INFECTION
$300,000Mcgill University · R01 · FY2003 · HL
M.tuberculosis Genes Regulating Persistent Infection
$300,000Medical College Of Wisconsin · R01 · FY2004 · AI
TRAINING PROGRAM IN TB AND HIV PREVENTION AND TREATMENT
$300,000New York University School Of Medicine · D43 · FY2003 · TW
Rapid and sensitive detection of TB in non-sputum samples and paucibacillary pleural fluid using a novel non-enzymatic isothermal assay platform to enable routine childhood TB screening
$300,000Ricardo Mancebo · Genendeavor, Llc · R43 · FY2016 · HD
3-Ketoacyl ACP Synthase III: A Novel Antibiotic Target
$300,000Virginia Commonwealth University · R01 · FY2004 · AI
Isolation and Antimalarial Activity of Small Molecules from Ocimum sanctum
$300,000Shuren Zhu · Radix Pharmaceuticals, Inc. · R43 · FY2009 · AI
Pre-Clinical Evaluation of Antimalarial Natural Products from Carica papaya L.
$300,000Shuren Zhu · Radix Pharmaceuticals, Inc. · R43 · FY2008 · AI
DEVELOPMENT OF PEDIATRIC TUBERCULOSIS TREATMENT
$300,000Zhigang Liu · Zymeron Corporation · N43 · FY2021 · AI
AFFINITY REAGENTS FOR THE IMMUNE SYSTEM OF GUINEA PIGS
$300,000Hong Qi · Qoolabs, Inc. · N43 · FY2020 · AI